Vident Advisory LLC boosted its holdings in Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) by 9.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,977 shares of the financial services provider's stock after purchasing an additional 1,234 shares during the quarter. Vident Advisory LLC's holdings in Marsh & McLennan Companies were worth $3,182,000 as of its most recent SEC filing.
Several other hedge funds have also recently modified their holdings of MMC. Financial Life Planners bought a new position in Marsh & McLennan Companies in the fourth quarter worth approximately $33,000. Sierra Ocean LLC acquired a new stake in Marsh & McLennan Companies in the fourth quarter valued at approximately $36,000. Albion Financial Group UT purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter valued at $38,000. Transce3nd LLC purchased a new position in Marsh & McLennan Companies during the 4th quarter worth $39,000. Finally, Golden State Wealth Management LLC purchased a new stake in Marsh & McLennan Companies during the 4th quarter worth approximately $41,000. Hedge funds and other institutional investors own 87.99% of the company's stock.
Insider Buying and Selling
In other news, CEO Dean Michael Klisura sold 7,121 shares of the business's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $234.97, for a total value of $1,673,221.37. Following the completion of the transaction, the chief executive officer now directly owns 20,935 shares of the company's stock, valued at $4,919,096.95. The trade was a 25.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Stacy Mills sold 1,317 shares of Marsh & McLennan Companies stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $234.97, for a total value of $309,455.49. Following the sale, the vice president now owns 2,923 shares of the company's stock, valued at approximately $686,817.31. This represents a 31.06% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 69,634 shares of company stock valued at $16,244,986. 0.35% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on MMC shares. Redburn Atlantic initiated coverage on shares of Marsh & McLennan Companies in a report on Tuesday, March 25th. They issued a "buy" rating and a $281.00 price target on the stock. Jefferies Financial Group boosted their price target on shares of Marsh & McLennan Companies from $237.00 to $244.00 and gave the stock a "hold" rating in a report on Friday, April 11th. UBS Group lifted their price target on Marsh & McLennan Companies from $259.00 to $261.00 and gave the stock a "buy" rating in a research note on Wednesday, April 9th. Wells Fargo & Company increased their price target on Marsh & McLennan Companies from $223.00 to $232.00 and gave the company an "equal weight" rating in a report on Thursday, April 10th. Finally, Barclays boosted their price objective on shares of Marsh & McLennan Companies from $246.00 to $249.00 and gave the company an "equal weight" rating in a report on Friday, April 11th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $241.93.
Get Our Latest Stock Report on MMC
Marsh & McLennan Companies Stock Performance
Shares of NYSE:MMC traded up $1.04 during trading on Monday, reaching $229.51. The company had a trading volume of 1,514,191 shares, compared to its average volume of 1,925,277. The company has a debt-to-equity ratio of 1.44, a current ratio of 1.13 and a quick ratio of 1.13. The stock's fifty day moving average price is $229.08 and its 200 day moving average price is $225.16. Marsh & McLennan Companies, Inc. has a fifty-two week low of $201.77 and a fifty-two week high of $248.00. The firm has a market capitalization of $113.08 billion, a price-to-earnings ratio of 28.02, a price-to-earnings-growth ratio of 2.70 and a beta of 0.85.
Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The financial services provider reported $3.06 EPS for the quarter, beating the consensus estimate of $3.02 by $0.04. Marsh & McLennan Companies had a return on equity of 32.60% and a net margin of 16.60%. The business had revenue of $6.70 billion during the quarter, compared to analysts' expectations of $7.08 billion. During the same period last year, the firm earned $2.89 EPS. As a group, equities research analysts predict that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current year.
Marsh & McLennan Companies Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 3rd were given a dividend of $0.815 per share. The ex-dividend date of this dividend was Thursday, April 3rd. This represents a $3.26 dividend on an annualized basis and a dividend yield of 1.42%. Marsh & McLennan Companies's payout ratio is 39.95%.
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Further Reading

Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.